NICE Endorses Pegzilarginase for Treating Argin...

By HEOR Staff Writer

February 17, 2026

NICE Backs Pegzilarginase for Arginase Deficiency The National Institute for Health and Care Excellence (NICE) final draft guidance recommends pegzilarginase arginase deficiency trea...
Late-Breaking Data on Bladder Cancer Treatments from KEYNOTE-B15 Trial
Robotic Surgery Portugal: A Landmark Achievement at ULS Viseu Dão-Lafões
Pharmaceutical Tender Investigation Sparks Regulatory Scrutiny in South Africa
Advancements in Uncertainty-Aware Diagnostics with ConfiDx LLM
Enhancing Early-Stage Cancer Treatment: Overcoming Barriers for Better Outcomes
National HealthTech Access: Transforming NHS Adoption and Equity
Tislelizumab NSCLC Inclusion Recommended for Dutch Health Package
AI Healthcare Costs: Navigating Financial Hurdles in Technology Integration
NICE Endorses Dupilumab for Eosinophilic COPD Treatment
NICE Endorses Talazoparib Enzalutamide for Prostate Cancer Treatment
Trump Economic Revival: Key Policies and Impacts from Davos 2026
EU Medicine Authorizations 2025: A Milestone for Innovation and Accessibility